Company Logo

brodalumab

Agricultural Biotechnology

Updated on Jun 1, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for brodalumab with ID of: 4247966
Recombinant monoclonal antibody to IL17A. Crenezumab is a humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.